Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
Clinical trial NCT02743078 · TERMINATED
Trial details
- NCT number
- NCT02743078
- Sponsor
- RTOG Foundation, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-09
- Primary completion
- 2019-10-15
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.